Please login to the form below

Not currently logged in
Email:
Password:

Allergan appoints Douglas Ingram as first president

Promotion for company veteran

Allergan-Douglas-IngramAllergan has appointed company veteran Douglas Ingram as the company's first president.

Ingram, who has spent 17 years at Allegan, will lead the company's global commercial operations, holding responsibility for a product portfolio that includes Botox as well as several ophthalmology treatments.

He most recently spent three years as executive VP and president, Europe, Africa and Middle East (EAME).

Other roles during his extensive period at Allergan include chief administrative officer and chief ethics officer.

He rose to these roles having joined the company as senior attorney and chief litigation officer in 1996.

Before joining Allergan, Ingram was an attorney with Gibson, Dunn & Crutcher from 1988, practicing in the area of complex commercial litigation.

"Doug has built an impressive record of accomplishment and is widely regarded throughout our organisation as a leader who is committed to the highest standards of excellence in all areas,” said David Pyott, chairman of the board and CEO, Allergan.

27th June 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics